Search
empagliflozin/linagliptin/metformin (Trijardy XR)
Indications:
- diabetes mellitus type 2
Dosage:
- once daily
Tablets:
- 5 mg empagliflozin/2.5 mg linagliptin/1000 mg metformin HCl extended-release
- 10 mg empagliflozin/5 mg linagliptin/1000 mg metformin HCl extended-release
- 12.5 mg empagliflozin/2.5 mg linagliptin/1000 mg metformin HCl extended-release
- 25 mg empagliflozin/5 mg linagliptin/1000 mg metformin HCl extended-release
Interactions
drug adverse effects of hypoglycemic agents
General
hypoglycemic combination
References
- Monaco K
FDA OK's Trijardy XR; Dual Hormone Artificial Pancreas -
News and commentary from the endocrinology world
MedPage Today January 31, 2020
https://www.medpagetoday.com/endocrinology/generalendocrinology/84653
- HIGHLIGHTS OF PRESCRIBING INFORMATION
Trijardy XR (empagliflozin, linagliptin, and metformin)
https://docs.boehringer-ingelheim.com/Prescribing%20Information/PIs/Trijardy%20XR/Trijardy%20XR.pdf?DMW_FORMAT=pdf
Components
empagliflozin (Jardiance)
linagliptin (Tradjenta)
metformin (Glucophage)